comparemela.com
Home
Live Updates
FDA approves gene therapies for sickle cell disease patients : comparemela.com
FDA approves gene therapies for sickle cell disease patients
The U.S. Food and Drug Administration (FDA) has given the green light to two new gene therapies, Casgevy and Lyfgenia, to treat sickle cell
Related Keywords
United States
,
Americans
,
Peter Marks
,
Casgevy To Vertex Pharmaceuticals Inc
,
Lyfgenia To Bluebird Bio Inc
,
Drug Administration
,
Biologics Evaluation
,
Vertex Pharmaceuticals
,
Bluebird Bio
,
comparemela.com © 2020. All Rights Reserved.